Cala® Health Closes Oversubscribed $50 Million Financing To Propel Growth
SAN MATEO, Calif., Dec. 9, 2024 /PRNewswire/ -- Cala Health, the non-invasive bioelectronic medicine leader, today announced it has completed...
Healthcare
SmarterDx Recognized as One of Modern Healthcare’s Best in Business Winners
SmarterDx honored in Newcomer - Startups category in program's inaugural year. NEW YORK, Dec. 9, 2024 /PRNewswire/ -- Today, Modern Healthcare...
Get Well Earns 2024 Fierce Healthcare Diversity, Equity, and Inclusion Award
Recognition highlights Get Well's maternal health equity and youth mental health programs BETHESDA, Md., Dec. 9, 2024 /PRNewswire/ -- Get...
CipherHealth Recognized as One of Modern Healthcare’s Best in Business
CipherHealth named a recipient of the 2024 Best in Business Awards in the Patient Experience & Engagement category NEW YORK,...
Arrive AI Revolutionizes Healthcare Logistics with Smart, Secure Delivery Hubs
Patented Technology Ensures Chain of Custody, Climate Control and Seamless Integration with Robots and Drones INDIANAPOLIS, Dec. 9, 2024 /PRNewswire/...
Longevity and Caregiving Conference Gathers Key Thought Leaders in Nation’s Capital to Discuss Transformational Changes for the $648B Care Economy
WASHINGTON, Dec. 9, 2024 /PRNewswire/ -- Thought leaders in longevity and caregiving will convene at the National Press Club here December...
Carta Healthcare to Power Oncology Research and Clinical Trials with Acquisition of Realyze Intelligence, a UPMC Enterprises Company
Clinician-trained AI analyzes electronic records to match ideal patients with studies in seconds rather than hours, optimizing research and reducing...
Study Results from COTA, PreciseDx, and Baptist Health South Florida Confirm Novel AI Test, PreciseBreast is Equivalent to Oncotype DX at Predicting Breast Cancer Recurrence
Findings to be Presented at the San Antonio Breast Cancer Symposium NEW YORK, Dec. 9, 2024 /PRNewswire/ -- COTA Inc., a...
Essen Health Care’s ACO REACH Program Achieves 22% Savings While Transforming Care for New York’s Most Vulnerable Populations
BRONX, N.Y., Dec. 9, 2024 /PRNewswire/ -- Essen Health Care is proud to announce the successful results of its 2023...
Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement with Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia
BOSTON, MA / ACCESSWIRE / December 9, 2024 / Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc....
NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App
JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast...
NEFHSC, Baptist Health & Philips Give Local Families Free Pregnancy+ App
JACKSONVILLE, Fla.--(BUSINESS WIRE)--To help ensure more families have access to educational resources they need for healthy birth outcomes, the Northeast...
T2 Biosystems Announces Plans to License its Proprietary Technology to Expand its Leadership in Direct-From-Whole-Blood Detection of Sepsis-Causing Pathogens
Intends to accelerate broad adoption of direct-from-whole-blood diagnostics, generate non-dilutive capital, and create a new royalty revenue streamLEXINGTON, Mass., Dec....
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision
DALLAS, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI)...
NCCN Prostate Cancer Guidelines Reinforce Status of Myriad Genetics’ Prolaris® Test as an ‘Advanced Tool’ Recommended for Prognostic Assessment
Prolaris Remains a Long-Standing Fixture in the Guidelines for 10th Year RunningSALT LAKE CITY, Dec. 09, 2024 (GLOBE NEWSWIRE) --...
Senseonics Holdings, Inc. Provides Update on Eversense 365 Launch
Strong Eversense® 365 early launch indicators illustrated by largest number of new patient shipments and largest number of prescribing providers...
Anavex Life Sciences to Report New Long-Term Oral Blarcamesine Phase IIb/III Alzheimer’s Disease Data at J.P. Morgan 2025 Healthcare Conference
Topline data from ATTENTION-AD Open-Label-Extension (OLE) 96/144-Week trial J.P. Morgan 2025 Healthcare Conference, taking place January 13–16, 2025, in San...
Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China’s NMPA
ST. LOUIS and SHANGHAI, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS) and Shanghai MicroPort EP Medtech Co., Ltd....
EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024
PRESS RELEASE EnnoDC presents preliminary data for immunotherapy candidate CD40.HVac in HPV+ oropharyngeal cancer at ESMO IO 2024 Paris, France,...
MEDIROM Healthcare Technologies Has Received Orders for Over 25,000 MOTHER Bracelet Units
TOKYO, Dec. 09, 2024 (GLOBE NEWSWIRE) -- MEDIROM Healthcare Technologies Inc. (NASDAQ: MRM) (“MEDIROM”) announces that its subsidiary MEDIROM MOTHER...